Coverage
-
October 31, 2018
The U.S. Department of Health and Human Services on Wednesday backed off its latest delay of drugmaker fines in the 340B drug discount program, a win for hospitals that sued to force implementation of the penalty policy.
1 other articles on this case.
View all »